Menarini International Operations Luxembourg SA
- C01 - Terapia cardíaca
- RANEXA prolonged-release tablet 375 mg
- RANEXA prolonged-release tablet 500 mg
- RANEXA prolonged-release tablet 750 mg
- C07 - Betabloqueantes
- LOBIVON PLUS film-coated tablet 5 mg+12.5 mg
- LOBIVON PLUS film-coated tablet 5 mg+25 mg
- LOBIVON tablet 5 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- OLARTAN film-coated tablet 10 mg
- OLARTAN film-coated tablet 20 mg
- OLARTAN film-coated tablet 40 mg
- OLARTAN-PLUS film-coated tablet 20 mg+12.5 mg
- OLARTAN-PLUS film-coated tablet 20 mg+25 mg
- OLARTAN-PLUS film-coated tablet 40 mg+12.5 mg
- OLARTAN-PLUS film-coated tablet 40 mg+25 mg
- ORIZAL film-coated tablet 20 mg+5 mg
- ORIZAL film-coated tablet 40 mg+10 mg
- ORIZAL film-coated tablet 40 mg+5 mg
- ORIZAL PLUS film-coated tablet 20 mg+5 mg+12.5 mg
- ORIZAL PLUS film-coated tablet 40 mg+10 mg+12.5 mg
- ORIZAL PLUS film-coated tablet 40 mg+10 mg+25 mg
- ORIZAL PLUS film-coated tablet 40 mg+5 mg+12.5 mg
- ORIZAL PLUS film-coated tablet 40 mg+5 mg+25 mg
- G04 - Urológicos
- SPEDRA tablet 100 mg
- SPEDRA tablet 200 mg
- SPEDRA tablet 50 mg
- M01 - Antiinflamatorios y antirreumáticos
- NOSATEL film-coated tablet 25 mg
- NOSATEL solution for injection 50 mg/2 ml
- M04 - Antigotosos
- ADENURIC film-coated tablet 120 mg
- ADENURIC film-coated tablet 80 mg
- N02 - Analgésicos
- SKUDEXA film-coated tablet 75 mg+25 mg
- R06 - Antihistamínicos para uso sistémico
- BILAZ oral solution 2.5 mg/ml
- BILAZ orodispersible tablet 10 mg
- BILAZ tablet 20 mg